Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yao Dai

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Oncotargets and Therapy|June 14, 2019
c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cellsYao Dai, Dietmar Siemann
BMC Cancer|May 30, 2012
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607Yao Dai, Dietmar W Siemann
Bulletin of Mathematical Biology|December 2, 2015
An Effect of Landmarks on Territory Shape in a Convict CichlidMike Mesterton-Gibbons, Yao Dai
Molecular Cancer Therapeutics|June 3, 2010
BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitroYao Dai, Dietmar W Siemann
Journal of the American Chemical Society|September 2, 2020
A Visible and Near-Infrared Light Activatable Diazocoumarin Probe for Fluorogenic Protein Labeling in Living CellsSheng-Yao Dai, Dan Yang
Current Atherosclerosis Reports|January 9, 2021
Novel Functions of Endothelial Scavenger Receptor Class B Type ILiming Yu, Yao Dai, Chieko Mineo
Frontiers in Pharmacology|March 21, 2022
DNA Methylation Aberrant in AtherosclerosisYao Dai, Danian Chen, Tingting Xu
Medicine|April 14, 2022
Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysisGuo-Yao Dai, Ye-Hua Zhu
Mathematical Biosciences|February 14, 2016
Modeling the evolution of winner and loser effects: A survey and prospectusMike Mesterton-Gibbons, Yao Dai, Marlène Goubault
Asian Journal of Andrology|November 22, 2011
Another road leads to HIF-1 activation: implications for prostate cancer progressionYao Dai, Kyungmi Bae, Dietmar W Siemann
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Oncotargets and Therapy|June 14, 2019
c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cellsYao Dai, Dietmar Siemann
BMC Cancer|May 30, 2012
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607Yao Dai, Dietmar W Siemann
Bulletin of Mathematical Biology|December 2, 2015
An Effect of Landmarks on Territory Shape in a Convict CichlidMike Mesterton-Gibbons, Yao Dai
Molecular Cancer Therapeutics|June 3, 2010
BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitroYao Dai, Dietmar W Siemann
Journal of the American Chemical Society|September 2, 2020
A Visible and Near-Infrared Light Activatable Diazocoumarin Probe for Fluorogenic Protein Labeling in Living CellsSheng-Yao Dai, Dan Yang
Current Atherosclerosis Reports|January 9, 2021
Novel Functions of Endothelial Scavenger Receptor Class B Type ILiming Yu, Yao Dai, Chieko Mineo
Frontiers in Pharmacology|March 21, 2022
DNA Methylation Aberrant in AtherosclerosisYao Dai, Danian Chen, Tingting Xu
Medicine|April 14, 2022
Clinical assessment of levamlodipine besylate combination therapy for essential hypertension: A protocol for systematic review and meta-analysisGuo-Yao Dai, Ye-Hua Zhu
Mathematical Biosciences|February 14, 2016
Modeling the evolution of winner and loser effects: A survey and prospectusMike Mesterton-Gibbons, Yao Dai, Marlène Goubault
Asian Journal of Andrology|November 22, 2011
Another road leads to HIF-1 activation: implications for prostate cancer progressionYao Dai, Kyungmi Bae, Dietmar W Siemann
Pageof 22